Federal drug pricing pressures intensified in 2025 with the second Trump administration. This Update reviews the year’s pivotal shifts and outlines what manufacturers should expect as they prepare for a more complex 2026.
The post U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026 appeared first on GoodLifeSci.